Veana

Veana Therapeutics is a clinical-stage biopharmaceutical company based in Portland, OR, focused on developing oral mitochondrial inhibitors to target cancer cells while sparing normal cells. The company is developing alpha-tocopheryloxyacetic acid-based treatments and has raised seed funding for its oncology pipeline.